Merck, Inc.

🇵🇭Philippines
Ownership
Subsidiary
Employees
-
Market Cap
$295.3B
Website
http://www.merck.ph

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

First Posted Date
2024-10-30
Last Posted Date
2024-12-05
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
160
Registration Number
NCT06664801
Locations
🇺🇸

Pulmonary Associates, PA ( Site 1903), Phoenix, Arizona, United States

🇺🇸

Norton Pulmonary Specialists ( Site 1935), Louisville, Kentucky, United States

🇬🇧

Golden Jubilee National Hospital ( Site 1800), Glasgow, Glasgow City, United Kingdom

and more 4 locations

A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2024-10-30
Last Posted Date
2024-10-30
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
12
Registration Number
NCT06665230
Locations
🇺🇸

Alliance for Multispecialty Research, LLC (Site 0001), Knoxville, Tennessee, United States

A Study of Diltiazem With a Single Dose of MK-6552 in Healthy Adult Participants (MK-6552-007)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2024-10-28
Last Posted Date
2024-10-28
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
14
Registration Number
NCT06662396
Locations
🇺🇸

ICON (Site 0001), Lenexa, Kansas, United States

A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2024-10-26
Last Posted Date
2024-10-26
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
8
Registration Number
NCT06658626
Locations
🇺🇸

Labcorp Clinical Research Unit Inc. (Site 0001), Madison, Wisconsin, United States

The Effect of Food and Water Volume in Healthy Adult Participants Administered Enlicitide Decanoate (MK-0616) (MK-0616-022)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2024-10-26
Last Posted Date
2024-10-26
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
34
Registration Number
NCT06658652
Locations
🇺🇸

Celerion (Site 0001), Lincoln, Nebraska, United States

A Study of Suvorexant (MK-4305) for the Treatment of Insomnia in Participants With Opioid Use Disorder (MK-4305-098)

Phase 3
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-10-24
Last Posted Date
2024-10-24
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
300
Registration Number
NCT06655883

A Study of Enlicitide Chloride (MK-0616) in Healthy Participants and Participants Taking Statins (MK-0616-012)

First Posted Date
2024-10-23
Last Posted Date
2024-10-23
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
56
Registration Number
NCT06655311
Locations
🇺🇸

Altasciences Clinical Kansas, Inc. (Site 0002), Overland Park, Kansas, United States

A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001)

Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2024-10-23
Last Posted Date
2024-12-19
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
200
Registration Number
NCT06655324
Locations
🇺🇸

California Clinical Trials Medical Group managed by PAREXEL ( Site 0011), Glendale, California, United States

🇺🇸

Alliance for Multispecialty Research, LLC ( Site 0008), Kansas City, Missouri, United States

🇺🇸

Velocity Clinical Research, Omaha ( Site 0005), Omaha, Nebraska, United States

and more 2 locations

MK-6194 Site of Injection Study in Healthy Adult Participants (MK-6194-013)

Phase 1
Completed
Conditions
Interventions
First Posted Date
2024-10-21
Last Posted Date
2024-10-21
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
16
Registration Number
NCT06649877
Locations
🇺🇸

QPS-MRA, LLC-Early Phase (Site 0001), South Miami, Florida, United States

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

First Posted Date
2024-10-21
Last Posted Date
2024-12-17
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
1349
Registration Number
NCT06651281
Locations
🇺🇸

Southern Star Research Institute ( Site 0299), San Antonio, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath